CEO & Co-Founder
BEng BSc PgDip
Over 15 years experience in medtech and entrepreneurial ventures. Tim drives the company’s commercial and technical activities, and enjoys liaising with healthcare professionals for patient-centric solutions.
Maeve Mc Walter
Maeve has 3 years’ experience in the medical device industry. With technical skills and strategic thinking, she is passionate about developing impactful solutions and improving patient care.
Suzanne Ryan has over 25 years’ experience in the healthcare sector in Ireland; having worked also in the areas of Consumer and Business to Business Marketing in Ireland and abroad for both MNCs and SMEs. She holds MBA, MBS qualifications and also has Diplomas in both Health Science and Corporate Governance. She has vast board experience as a member of various Educational and Philanthropic Boards. She was appointed to the position of Chairperson of the Board of SymPhysis Medical in 2021.
Dr. Michelle Tierney
CSO & Co-Founder
BSc MSc PhD
Michelle has more than 10 years experience in the life sciences sector. A former Pharmacologist, she is motivated by delivering clinical solutions that improve palliative care and people’s quality of life.
Sandra O'Halloran Senior DA Engineer
With 16 years’ experience, Sandra's extensive expertise in design assurance ensures that all designs adhere to the highest standards of design, quality, and regulatory requirements. Her track record includes leading and contributing to the successful launch of multiple innovative Medical Device products across global markets.
Mike Ryan is the
founder investor and Board member from 2005 of Sedana Medical which was listed on the (Nasdaq) First North stock exchange in June 2017. Former CEO of Sedana Medical (2011-2017). Mike was also the main shareholder and CEO of Artema Medical AB from 2003 and led the sale of Artema to Datascope Corporation in 2007. Investor return was 16X on initial investment in 4 years. Founder Director of Irrus Investments – the largest angel investment syndicate in Ireland which has invested over €40 million in 35 early-stage technology companies in Ireland and internationally.
BSC CSQP CMDA
Trevor has over 25 years’ experience in Quality roles within the medical device industry. He has an in-depth knowledge of FDA and EU regulations, and extensive experience delivering process and cost improvements.
Nate Reynolds Operations Admin
Nate has worked in Administration for 12 years on three continents. His thorough experience in both the public and private sector allows him a helicopter view of requirements and possible issues in the day-to-day running of the office.
Philip Hendrick is currently CEO of Galway Centre for Independent Living, a former Business Partner with Enterprise Ireland and has over 25 years experience in the respiratory home care services sector, where he has held various commercial management roles. An active angel investor, he is a member of the HBAN WxNW Syndicate, with a keen interest in Medtech, Disruptive Technologies and Eco-innovation.
Stuart Deane Principal R&D Engineer
DPL MSC BAI
Stuart has spent a decade working in medical device devlopment and in Contract Manufacturing with multinationals and startups from concept to clinical trial. He leads the R&D team in bringing technology through the development pathway.
Richard Watson is Managing Partner of Further VC, one of the most active early-stage venture capital investors in the country. He has invested in circa 50 software, medical device and high-tech early-stage companies in Ireland and the UK through a number of venture funds over the past 15 years.
Richard started his career in R&D and product development with two medical start-ups in Sweden, in the areas of electro-diagnostics and drug delivery. He also worked with Intel in manufacturing and operations and was involved in the establishment and ramp-up of Fab 24, one of Intel’s main global manufacturing facilities.
Oonagh has over 20 years' expereince in Programme Management and Product Management roles. She has extensive experience in developing and launching new products across the global medical device industry.